Addimmune: Is a Clinical-Stage Gene and Cell Therapy Co Developing a Functional Cure for HIV, Prior to the Combination, Non-HIV Assets Will Spin Off Into Entity That Will Retain the Amer Gene Technologies Name >VCXB.U
Addimmune: Is a Clinical-Stage Gene and Cell Therapy Co Developing a Functional Cure for HIV, Prior to the Combination, Non-HIV Assets Will Spin Off Into Entity That Will Retain the Amer Gene Technologies Name >VCXB.U
Addimmune：是一家臨床階段的基因和細胞療法公司正在開發HIV的功能性治療方法，在合併之前，非HIV資產將分拆爲保留Amer Gene Technologies名稱的實體 >VCXB.U
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊